Structure

Physi-Chem Properties

Molecular Weight:  802.38
Volume:  806.251
LogP:  4.201
LogD:  2.972
LogS:  -4.728
# Rotatable Bonds:  11
TPSA:  199.65
# H-Bond Aceptor:  15
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.212
Synthetic Accessibility Score:  6.519
Fsp3:  0.643
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.059
MDCK Permeability:  7.597146759508178e-05
Pgp-inhibitor:  0.981
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.112
20% Bioavailability (F20%):  0.05
30% Bioavailability (F30%):  0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.019
Plasma Protein Binding (PPB):  92.7441635131836%
Volume Distribution (VD):  1.617
Pgp-substrate:  3.5956649780273438%

ADMET: Metabolism

CYP1A2-inhibitor:  0.019
CYP1A2-substrate:  0.083
CYP2C19-inhibitor:  0.335
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.848
CYP2C9-substrate:  0.062
CYP2D6-inhibitor:  0.668
CYP2D6-substrate:  0.046
CYP3A4-inhibitor:  0.957
CYP3A4-substrate:  0.227

ADMET: Excretion

Clearance (CL):  1.825
Half-life (T1/2):  0.773

ADMET: Toxicity

hERG Blockers:  0.722
Human Hepatotoxicity (H-HT):  0.991
Drug-inuced Liver Injury (DILI):  0.939
AMES Toxicity:  0.238
Rat Oral Acute Toxicity:  0.625
Maximum Recommended Daily Dose:  0.047
Skin Sensitization:  0.869
Carcinogencity:  0.039
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.057

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC141970

Natural Product ID:  NPC141970
Common Name*:   Ipomoeassin A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  UIMJTDXGFNDFRJ-ZOHZRQPWSA-N
Standard InCHI:  InChI=1S/C42H58O15/c1-6-15-30-19-14-9-8-13-18-29(44)21-23-32(45)50-24-31-37(55-33(46)22-20-28-16-11-10-12-17-28)38(56-40(49)25(3)7-2)35(48)41(54-31)57-39-34(47)36(52-27(5)43)26(4)51-42(39)53-30/h7,10-12,16-17,20,22,26,30-31,34-39,41-42,47-48H,6,8-9,13-15,18-19,21,23-24H2,1-5H3/b22-20+,25-7+/t26-,30+,31-,34+,35-,36+,37-,38-,39-,41+,42+/m1/s1
SMILES:  CCC[C@H]1CCCCCCC(=O)CCC(=O)OC[C@H]2O[C@@H](O[C@H]3[C@H](O1)O[C@H](C)[C@@H]([C@@H]3O)OC(=O)C)[C@H](O)[C@H]([C@@H]2OC(=O)/C=C/c1ccccc1)OC(=O)/C(=C/C)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL506305
PubChem CID:   11308828
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003918] Saccharolipids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17901 Ipomoea squamosa Species Convolvulaceae Eukaryota leaves Suriname rainforest n.a. PMID[15844934]
NPO17901 Ipomoea squamosa Species Convolvulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 = 500.0 nM PMID[507004]
NPT165 Cell Line HeLa Homo sapiens IC50 = 64.0 nM PMID[507005]
NPT1460 Cell Line L929 Mus musculus IC50 = 77.8 nM PMID[507005]
NPT179 Cell Line A2780 Homo sapiens IC50 = 500.0 nM PMID[507005]
NPT466 Cell Line U-937 Homo sapiens IC50 = 20.2 nM PMID[507005]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 46.1 nM PMID[507005]
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 = 42.6 nM PMID[507005]
NPT2 Others Unspecified IC50 = 108.9 nM PMID[507005]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC141970 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC140561
0.9583 High Similarity NPC231627
0.9504 High Similarity NPC226101
0.9504 High Similarity NPC237182
0.9483 High Similarity NPC476096
0.9333 High Similarity NPC162925
0.9333 High Similarity NPC87153
0.9256 High Similarity NPC28069
0.9256 High Similarity NPC77651
0.918 High Similarity NPC198918
0.918 High Similarity NPC204214
0.918 High Similarity NPC10121
0.918 High Similarity NPC92283
0.918 High Similarity NPC10883
0.918 High Similarity NPC63404
0.918 High Similarity NPC35338
0.918 High Similarity NPC124878
0.918 High Similarity NPC231888
0.918 High Similarity NPC290276
0.9106 High Similarity NPC471025
0.9091 High Similarity NPC473881
0.9032 High Similarity NPC471024
0.8957 High Similarity NPC470825
0.8871 High Similarity NPC471026
0.8871 High Similarity NPC147032
0.871 High Similarity NPC57607
0.8696 High Similarity NPC184633
0.8651 High Similarity NPC148026
0.8644 High Similarity NPC474641
0.8571 High Similarity NPC114096
0.856 High Similarity NPC244454
0.8516 High Similarity NPC11025
0.845 Intermediate Similarity NPC289415
0.845 Intermediate Similarity NPC319995
0.8438 Intermediate Similarity NPC301857
0.8417 Intermediate Similarity NPC29607
0.839 Intermediate Similarity NPC43584
0.8308 Intermediate Similarity NPC17567
0.8261 Intermediate Similarity NPC469527
0.8258 Intermediate Similarity NPC322503
0.8258 Intermediate Similarity NPC470143
0.8248 Intermediate Similarity NPC111466
0.824 Intermediate Similarity NPC229600
0.8231 Intermediate Similarity NPC27712
0.8189 Intermediate Similarity NPC138798
0.8188 Intermediate Similarity NPC40085
0.8188 Intermediate Similarity NPC264270
0.8175 Intermediate Similarity NPC284957
0.812 Intermediate Similarity NPC38420
0.812 Intermediate Similarity NPC136608
0.8092 Intermediate Similarity NPC473443
0.8083 Intermediate Similarity NPC30563
0.8015 Intermediate Similarity NPC475195
0.8015 Intermediate Similarity NPC225103
0.8 Intermediate Similarity NPC276061
0.8 Intermediate Similarity NPC474148
0.7984 Intermediate Similarity NPC145287
0.797 Intermediate Similarity NPC235294
0.797 Intermediate Similarity NPC46137
0.797 Intermediate Similarity NPC80599
0.7955 Intermediate Similarity NPC472388
0.7941 Intermediate Similarity NPC471345
0.7939 Intermediate Similarity NPC106677
0.7926 Intermediate Similarity NPC169398
0.791 Intermediate Similarity NPC159811
0.7883 Intermediate Similarity NPC65262
0.7883 Intermediate Similarity NPC469364
0.7883 Intermediate Similarity NPC101686
0.7868 Intermediate Similarity NPC263829
0.7863 Intermediate Similarity NPC276047
0.7863 Intermediate Similarity NPC267733
0.7846 Intermediate Similarity NPC317163
0.7842 Intermediate Similarity NPC475513
0.7842 Intermediate Similarity NPC473755
0.7836 Intermediate Similarity NPC209851
0.7836 Intermediate Similarity NPC246869
0.7836 Intermediate Similarity NPC138777
0.7836 Intermediate Similarity NPC281798
0.7836 Intermediate Similarity NPC225384
0.7826 Intermediate Similarity NPC324262
0.7826 Intermediate Similarity NPC62800
0.7817 Intermediate Similarity NPC212808
0.7808 Intermediate Similarity NPC87403
0.7803 Intermediate Similarity NPC288416
0.7801 Intermediate Similarity NPC471028
0.7801 Intermediate Similarity NPC202391
0.7801 Intermediate Similarity NPC296659
0.7786 Intermediate Similarity NPC148080
0.7786 Intermediate Similarity NPC469623
0.7778 Intermediate Similarity NPC329657
0.7761 Intermediate Similarity NPC305162
0.7761 Intermediate Similarity NPC475478
0.7755 Intermediate Similarity NPC477735
0.773 Intermediate Similarity NPC293154
0.773 Intermediate Similarity NPC478250
0.7727 Intermediate Similarity NPC471157
0.7727 Intermediate Similarity NPC252114
0.7721 Intermediate Similarity NPC114116
0.7714 Intermediate Similarity NPC80098
0.7714 Intermediate Similarity NPC79908
0.7704 Intermediate Similarity NPC478255
0.7704 Intermediate Similarity NPC475569
0.7704 Intermediate Similarity NPC471880
0.7703 Intermediate Similarity NPC477736
0.7698 Intermediate Similarity NPC31745
0.7698 Intermediate Similarity NPC220936
0.7692 Intermediate Similarity NPC52097
0.7686 Intermediate Similarity NPC20485
0.7671 Intermediate Similarity NPC69425
0.7669 Intermediate Similarity NPC45224
0.7669 Intermediate Similarity NPC471881
0.7669 Intermediate Similarity NPC195224
0.7669 Intermediate Similarity NPC156692
0.7669 Intermediate Similarity NPC471882
0.7669 Intermediate Similarity NPC103533
0.7669 Intermediate Similarity NPC175333
0.7669 Intermediate Similarity NPC173150
0.7669 Intermediate Similarity NPC35288
0.7669 Intermediate Similarity NPC230331
0.7667 Intermediate Similarity NPC152384
0.7667 Intermediate Similarity NPC37714
0.7664 Intermediate Similarity NPC34456
0.7655 Intermediate Similarity NPC96599
0.7655 Intermediate Similarity NPC478242
0.7655 Intermediate Similarity NPC469415
0.7652 Intermediate Similarity NPC470818
0.7652 Intermediate Similarity NPC470816
0.7652 Intermediate Similarity NPC126991
0.7652 Intermediate Similarity NPC79608
0.7652 Intermediate Similarity NPC123704
0.7652 Intermediate Similarity NPC476033
0.7652 Intermediate Similarity NPC83218
0.7643 Intermediate Similarity NPC77493
0.7642 Intermediate Similarity NPC264784
0.7638 Intermediate Similarity NPC216605
0.7638 Intermediate Similarity NPC266389
0.7638 Intermediate Similarity NPC122245
0.7634 Intermediate Similarity NPC469742
0.763 Intermediate Similarity NPC469705
0.763 Intermediate Similarity NPC470122
0.763 Intermediate Similarity NPC17968
0.7622 Intermediate Similarity NPC477737
0.7619 Intermediate Similarity NPC469456
0.7619 Intermediate Similarity NPC106818
0.7615 Intermediate Similarity NPC475328
0.7615 Intermediate Similarity NPC11724
0.7612 Intermediate Similarity NPC225307
0.7607 Intermediate Similarity NPC262826
0.7606 Intermediate Similarity NPC152796
0.7606 Intermediate Similarity NPC475213
0.7606 Intermediate Similarity NPC242756
0.7606 Intermediate Similarity NPC469367
0.7603 Intermediate Similarity NPC35097
0.7603 Intermediate Similarity NPC117346
0.7603 Intermediate Similarity NPC240592
0.76 Intermediate Similarity NPC172525
0.76 Intermediate Similarity NPC474363
0.7594 Intermediate Similarity NPC61181
0.7594 Intermediate Similarity NPC473423
0.7589 Intermediate Similarity NPC47471
0.7589 Intermediate Similarity NPC476377
0.7586 Intermediate Similarity NPC28776
0.7586 Intermediate Similarity NPC222102
0.7586 Intermediate Similarity NPC303429
0.7586 Intermediate Similarity NPC120728
0.7586 Intermediate Similarity NPC473138
0.7586 Intermediate Similarity NPC469448
0.7584 Intermediate Similarity NPC477467
0.7583 Intermediate Similarity NPC47286
0.7574 Intermediate Similarity NPC475493
0.7571 Intermediate Similarity NPC472350
0.7571 Intermediate Similarity NPC476383
0.7571 Intermediate Similarity NPC473440
0.7571 Intermediate Similarity NPC197316
0.7571 Intermediate Similarity NPC89105
0.7571 Intermediate Similarity NPC81515
0.7571 Intermediate Similarity NPC68092
0.7571 Intermediate Similarity NPC64141
0.7569 Intermediate Similarity NPC473147
0.7569 Intermediate Similarity NPC474268
0.7569 Intermediate Similarity NPC143246
0.7569 Intermediate Similarity NPC291153
0.7569 Intermediate Similarity NPC475539
0.7569 Intermediate Similarity NPC119773
0.7556 Intermediate Similarity NPC253595
0.7556 Intermediate Similarity NPC469549
0.7554 Intermediate Similarity NPC472132
0.7552 Intermediate Similarity NPC194938
0.7551 Intermediate Similarity NPC475379
0.755 Intermediate Similarity NPC165234
0.755 Intermediate Similarity NPC475536
0.7538 Intermediate Similarity NPC476872
0.7535 Intermediate Similarity NPC245219
0.7535 Intermediate Similarity NPC65833
0.7535 Intermediate Similarity NPC296643
0.7535 Intermediate Similarity NPC31081
0.7518 Intermediate Similarity NPC472248
0.7518 Intermediate Similarity NPC15850
0.7518 Intermediate Similarity NPC475530
0.7518 Intermediate Similarity NPC471095

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC141970 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8462 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD7266 Discontinued
0.7569 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6647 Phase 2
0.728 Intermediate Similarity NPD2067 Discontinued
0.725 Intermediate Similarity NPD7798 Approved
0.7236 Intermediate Similarity NPD5048 Discontinued
0.7167 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD969 Suspended
0.7068 Intermediate Similarity NPD5126 Approved
0.7068 Intermediate Similarity NPD5125 Phase 3
0.7063 Intermediate Similarity NPD2182 Approved
0.7059 Intermediate Similarity NPD8455 Phase 2
0.704 Intermediate Similarity NPD6685 Approved
0.7016 Intermediate Similarity NPD5909 Discontinued
0.6984 Remote Similarity NPD6686 Approved
0.6975 Remote Similarity NPD5122 Clinical (unspecified phase)
0.6929 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6010 Discontinued
0.6892 Remote Similarity NPD6190 Approved
0.687 Remote Similarity NPD2629 Approved
0.6852 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6848 Remote Similarity NPD8312 Approved
0.6848 Remote Similarity NPD8313 Approved
0.6835 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6822 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6815 Remote Similarity NPD4381 Clinical (unspecified phase)
0.68 Remote Similarity NPD5765 Approved
0.68 Remote Similarity NPD5738 Clinical (unspecified phase)
0.679 Remote Similarity NPD7799 Discontinued
0.6769 Remote Similarity NPD6912 Phase 3
0.6748 Remote Similarity NPD9495 Approved
0.6748 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6746 Remote Similarity NPD164 Approved
0.6742 Remote Similarity NPD690 Clinical (unspecified phase)
0.6727 Remote Similarity NPD7685 Pre-registration
0.6715 Remote Similarity NPD1091 Approved
0.6711 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6694 Remote Similarity NPD2066 Phase 3
0.6692 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6646 Remote Similarity NPD7054 Approved
0.6644 Remote Similarity NPD7097 Phase 1
0.6639 Remote Similarity NPD689 Discontinued
0.6627 Remote Similarity NPD8368 Discontinued
0.6618 Remote Similarity NPD8516 Approved
0.6618 Remote Similarity NPD8515 Approved
0.6618 Remote Similarity NPD8517 Approved
0.6618 Remote Similarity NPD8513 Phase 3
0.6606 Remote Similarity NPD7472 Approved
0.6606 Remote Similarity NPD7074 Phase 3
0.66 Remote Similarity NPD4628 Phase 3
0.6597 Remote Similarity NPD6233 Phase 2
0.6587 Remote Similarity NPD1932 Approved
0.6587 Remote Similarity NPD7808 Phase 3
0.6585 Remote Similarity NPD7228 Approved
0.6583 Remote Similarity NPD46 Approved
0.6583 Remote Similarity NPD6698 Approved
0.6567 Remote Similarity NPD4198 Discontinued
0.6565 Remote Similarity NPD8413 Clinical (unspecified phase)
0.656 Remote Similarity NPD1238 Approved
0.6558 Remote Similarity NPD5403 Approved
0.6547 Remote Similarity NPD6637 Approved
0.6544 Remote Similarity NPD9545 Approved
0.6538 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6536 Remote Similarity NPD5401 Approved
0.6531 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6527 Remote Similarity NPD6559 Discontinued
0.6527 Remote Similarity NPD7251 Discontinued
0.6522 Remote Similarity NPD7829 Approved
0.6522 Remote Similarity NPD7830 Approved
0.6519 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6519 Remote Similarity NPD694 Clinical (unspecified phase)
0.6516 Remote Similarity NPD1653 Approved
0.651 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6509 Remote Similarity NPD8407 Phase 2
0.65 Remote Similarity NPD5346 Phase 2
0.65 Remote Similarity NPD7075 Discontinued
0.65 Remote Similarity NPD5347 Phase 2
0.6488 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6485 Remote Similarity NPD3818 Discontinued
0.6484 Remote Similarity NPD1237 Approved
0.6483 Remote Similarity NPD7961 Discontinued
0.6478 Remote Similarity NPD5402 Approved
0.6471 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6471 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6471 Remote Similarity NPD1282 Approved
0.6471 Remote Similarity NPD4793 Discontinued
0.6467 Remote Similarity NPD6797 Phase 2
0.6466 Remote Similarity NPD6858 Approved
0.6466 Remote Similarity NPD7094 Approved
0.6456 Remote Similarity NPD37 Approved
0.6446 Remote Similarity NPD3673 Approved
0.6446 Remote Similarity NPD7838 Discovery
0.6446 Remote Similarity NPD3672 Approved
0.6438 Remote Similarity NPD4966 Approved
0.6438 Remote Similarity NPD4967 Phase 2
0.6438 Remote Similarity NPD4965 Approved
0.6433 Remote Similarity NPD4380 Phase 2
0.6429 Remote Similarity NPD7240 Approved
0.6414 Remote Similarity NPD6798 Discontinued
0.6414 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6412 Remote Similarity NPD2329 Discontinued
0.6408 Remote Similarity NPD2625 Approved
0.6408 Remote Similarity NPD2628 Approved
0.6408 Remote Similarity NPD2160 Approved
0.6408 Remote Similarity NPD2627 Approved
0.6408 Remote Similarity NPD2626 Approved
0.6408 Remote Similarity NPD2159 Approved
0.6406 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6406 Remote Similarity NPD1929 Approved
0.6406 Remote Similarity NPD1930 Approved
0.6405 Remote Similarity NPD7236 Approved
0.6395 Remote Similarity NPD230 Phase 1
0.6389 Remote Similarity NPD2613 Approved
0.6384 Remote Similarity NPD7700 Phase 2
0.6384 Remote Similarity NPD7699 Phase 2
0.6382 Remote Similarity NPD8166 Discontinued
0.6382 Remote Similarity NPD2575 Approved
0.6379 Remote Similarity NPD226 Approved
0.6364 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6085 Phase 2
0.6364 Remote Similarity NPD1317 Discontinued
0.6364 Remote Similarity NPD6799 Approved
0.6364 Remote Similarity NPD5647 Approved
0.6358 Remote Similarity NPD6234 Discontinued
0.6357 Remote Similarity NPD4806 Approved
0.6357 Remote Similarity NPD4807 Approved
0.6354 Remote Similarity NPD8320 Phase 1
0.6354 Remote Similarity NPD8319 Approved
0.6352 Remote Similarity NPD6801 Discontinued
0.6349 Remote Similarity NPD5926 Approved
0.6346 Remote Similarity NPD6980 Clinical (unspecified phase)
0.634 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6337 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6335 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6331 Remote Similarity NPD5306 Approved
0.6331 Remote Similarity NPD5305 Approved
0.632 Remote Similarity NPD1989 Approved
0.6316 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6316 Remote Similarity NPD1652 Phase 2
0.6312 Remote Similarity NPD7819 Suspended
0.6306 Remote Similarity NPD7239 Suspended
0.6304 Remote Similarity NPD7741 Discontinued
0.6301 Remote Similarity NPD3764 Approved
0.6287 Remote Similarity NPD3751 Discontinued
0.6286 Remote Similarity NPD4106 Approved
0.6286 Remote Similarity NPD4135 Approved
0.6286 Remote Similarity NPD4136 Approved
0.6284 Remote Similarity NPD6355 Discontinued
0.6284 Remote Similarity NPD1933 Approved
0.6277 Remote Similarity NPD7641 Discontinued
0.6276 Remote Similarity NPD5203 Approved
0.6276 Remote Similarity NPD5201 Approved
0.6276 Remote Similarity NPD4617 Approved
0.6276 Remote Similarity NPD6832 Phase 2
0.6276 Remote Similarity NPD4620 Approved
0.6272 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6271 Remote Similarity NPD9491 Approved
0.6267 Remote Similarity NPD7033 Discontinued
0.6266 Remote Similarity NPD7458 Discontinued
0.6266 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6264 Remote Similarity NPD8360 Approved
0.6264 Remote Similarity NPD8361 Approved
0.6264 Remote Similarity NPD8435 Approved
0.626 Remote Similarity NPD7983 Approved
0.6259 Remote Similarity NPD4745 Approved
0.6259 Remote Similarity NPD2572 Clinical (unspecified phase)
0.6259 Remote Similarity NPD2574 Discontinued
0.6259 Remote Similarity NPD3089 Approved
0.6259 Remote Similarity NPD2573 Approved
0.6259 Remote Similarity NPD3615 Approved
0.6259 Remote Similarity NPD3616 Approved
0.6259 Remote Similarity NPD2571 Approved
0.6259 Remote Similarity NPD3087 Approved
0.6259 Remote Similarity NPD3090 Approved
0.6259 Remote Similarity NPD4746 Phase 3
0.6259 Remote Similarity NPD3614 Approved
0.6259 Remote Similarity NPD2570 Approved
0.6259 Remote Similarity NPD3088 Approved
0.6259 Remote Similarity NPD4062 Phase 3
0.6259 Remote Similarity NPD2566 Approved
0.6243 Remote Similarity NPD8150 Discontinued
0.6243 Remote Similarity NPD8434 Phase 2
0.6242 Remote Similarity NPD6653 Approved
0.6241 Remote Similarity NPD6287 Discontinued
0.624 Remote Similarity NPD1693 Approved
0.6233 Remote Similarity NPD7008 Discontinued
0.623 Remote Similarity NPD800 Approved
0.6224 Remote Similarity NPD5667 Approved
0.6216 Remote Similarity NPD5119 Approved
0.6216 Remote Similarity NPD5121 Approved
0.6216 Remote Similarity NPD5120 Approved
0.6215 Remote Similarity NPD6534 Approved
0.6215 Remote Similarity NPD6535 Approved
0.6209 Remote Similarity NPD7435 Discontinued
0.6197 Remote Similarity NPD8451 Approved
0.619 Remote Similarity NPD3268 Approved
0.619 Remote Similarity NPD2313 Discontinued
0.6188 Remote Similarity NPD7411 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data